<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19846582</PMID><DateCompleted><Year>2010</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>Pt 12</Issue><PubDate><Year>2009</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Clinical features of spinal and bulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>3242</StartPage><EndPage>3251</EndPage><MedlinePgn>3242-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awp258</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy is an X-linked motor neuron disease caused by a CAG repeat expansion in the androgen receptor gene. To characterize the natural history and define outcome measures for clinical trials, we assessed the clinical history, laboratory findings and muscle strength and function in 57 patients with genetically confirmed disease. We also administered self-assessment questionnaires for activities of daily living, quality of life and erectile function. We found an average delay of over 5 years from onset of weakness to diagnosis. Muscle strength and function correlated directly with serum testosterone levels and inversely with CAG repeat length, age and duration of weakness. Motor unit number estimation was decreased by about half compared to healthy controls. Sensory nerve action potentials were reduced in nearly all subjects. Quantitative muscle assessment and timed 2 min walk may be useful as meaningful indicators of disease status. The direct correlation of testosterone levels with muscle strength indicates that androgens may have a positive effect on muscle function in spinal and bulbar muscular atrophy patients, in addition to the toxic effects described in animal models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rhodes</LastName><ForeName>Lindsay E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, NINDS, NIH, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Brandi K</ForeName><Initials>BK</Initials></Author><Author ValidYN="Y"><LastName>Auh</LastName><ForeName>Sungyoung</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kokkinis</LastName><ForeName>Angela D</ForeName><Initials>AD</Initials></Author><Author ValidYN="Y"><LastName>La Pean</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Cheunju</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lehky</LastName><ForeName>Tanya J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Shrader</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Ellen W</ForeName><Initials>EW</Initials></Author><Author ValidYN="Y"><LastName>Harris-Love</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Di Prospero</LastName><ForeName>Nicholas A</ForeName><Initials>NA</Initials></Author><Author ValidYN="Y"><LastName>Fischbeck</LastName><ForeName>Kenneth H</ForeName><Initials>KH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000728" MajorTopicYN="N">Androgens</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004568" MajorTopicYN="N">Electrodiagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007172" MajorTopicYN="N">Erectile Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="N">Exercise Tolerance</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="N">Muscle Weakness</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009431" MajorTopicYN="N">Neural Conduction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010525" MajorTopicYN="N">Peripheral Nerves</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19846582</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pii">awp258</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andres PL, Skerry LM, Thornell B, Portney LG, Finison LJ, Munsat TL. A comparison of three measures of disease progression in ALS. J Neurol Sci. 1996;139 Suppl:64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">8899661</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini G, Gragnani F, Romaniello A, Pennisi EM, Morino S, Ceschin V, et al. Sensory involvement in spinal-bulbar muscular atrophy (Kennedy's disease) Muscle Nerve. 2000;23:252&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10639619</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, et al. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain. 2006;129:1446&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol. 2009;65:140&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">19259967</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks D, Davis AM, Naglie G. The feasibility of six-minute and two-minute walk tests in in-patient geriatric rehabilitation. Can J Aging. 2007;26:159&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">17613447</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen ES, O'Brien CJ, Wang H, Jenkins SC, Holder L, Lieberman AP, et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci. 2004;24:4778&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejager S, Bry-Gauillard H, Bruckert E, Eymard B, Salachas F, LeGuern E, et al. A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab. 2002;87:3893&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161529</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinsmore WW, Hodges M, Hargreaves C, Osterloh IH, Smith MD, Rosen RC. Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology. 1999;53:800&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10197860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante MA, Wilbourn AJ. The characteristic electrodiagnostic features of Kennedy's disease. Muscle Nerve. 1997;20:323&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9052811</ArticleId></ArticleIdList></Reference><Reference><Citation>Finas D, Bals-Pratsch M, Sandmann J, Eichenauer R, Jocham D, Diedrich K, et al. Quality of life in elderly men with androgen deficiency. Andrologia. 2006;38:48&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">16529575</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Doyu M, Minamiyama M, Sang C, Kobayashi Y, et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med. 2003;9:768&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">12754502</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Waza M, Banno H, Suzuki K, Tanaka F, et al. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA) Exp Neurol. 2006;200:8&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">16513111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada androgen receptor, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanowa-Petrusewicz I, et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1992;2:301&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303283</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada androgen receptor, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehky T, Chen C, Di Prospero N, Rhodes L, Fischbeck K, Floeter MK. Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy. Muscle Nerve. 2009 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763967</ArticleId><ArticleId IdType="pubmed">19670325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Fischbeck KH. Triplet repeat expansion in neuromuscular disease. Muscle Nerve. 2000;23:843&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">10842259</ArticleId></ArticleIdList></Reference><Reference><Citation>Light KE, Behrman AL, Thigpen M, Triggs WJ. The 2-minute walk test: A tool for evaluating walking endurance in clients with Parkinson's disease. Neurol Rep. 1997;21:136&#x2013;9.</Citation></Reference><Reference><Citation>Litman HJ, Bhasin S, O'Leary MP, Link CL, McKinlay JB. An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int. 2007;100:321&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17506868</ArticleId></ArticleIdList></Reference><Reference><Citation>Liveson JA, Ma DM. Laboratory reference for clinical neurophysiology. New York, NY: Oxford University Press; 1992.</Citation></Reference><Reference><Citation>Lund A, Udd B, Juvonen V, Andersen PM, Cederquist K, Ronnevi LO, et al. Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia. Eur J Hum Genet. 2000;8:631&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10951525</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu J, Boivin H, Richards CL. Quantitative motor assessment in myotonic dystrophy. Can J Neurol Sci. 2003;30:129&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">12774952</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller P, Moreland J, Stevenson T. Measurement properties of a standardized version of the two-minute walk test for individuals with neurological dysfunction. Physiother Can. 2002;54:241&#x2013;58.</Citation></Reference><Reference><Citation>Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J, Barrett-Connor E, et al. Testosterone and estradiol among older men. J Clin Endocrinol Metab. 2006;91:1336&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">16368750</ArticleId></ArticleIdList></Reference><Reference><Citation>Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Freeman JA, Jenkinson C, et al. Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. J Neurol Neurosurg Psychiatry. 2003;74:710&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1738466</ArticleId><ArticleId IdType="pubmed">12754336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen RC, Cappelleri JC, Gendrano N., III The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">12152111</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">9187685</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossier P, Wade DT. Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment. Arch Phys Med Rehabil. 2001;82:9&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">11239279</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt BJ, Greenberg CR, Allingham-Hawkins DJ, Spriggs EL. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology. 2002;59:770&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">12221177</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Cudkowicz ME, Zhang H, Schoenfeld D, Jillapalli D. The use of statistical MUNE in a multicenter clinical trial. Muscle Nerve. 2004;30:463&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15316983</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G, Doyu M, Kachi T, Yasuda T, Mukai E, Kumagai T, et al. Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy. J Neurol Sci. 1993;117:74&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8410070</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, et al. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology. 2005;64:1261&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">15824358</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2008;131:229&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">18056738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka F, Doyu M, Ito Y, Matsumoto M, Mitsuma T, Abe K, et al. Founder effect in spinal and bulbar muscular atrophy (SBMA) Hum Molec Genet. 1996;5:1253&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8872464</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukagoshi H, Nakanishi T, Kondo K, Tsubaki T. Hereditary proximal neurogenic muscular atrophy in adult. Arch Neurol. 1965;12:597&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">14295959</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User's manual for the SF-36v2 Health Survey. Lincoln, RI: QualityMetric Incorporated; 2007.</Citation></Reference><Reference><Citation>Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, et al. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev. 1995;4:735&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">8672990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>